JP2023516925A5 - - Google Patents
Info
- Publication number
- JP2023516925A5 JP2023516925A5 JP2022550778A JP2022550778A JP2023516925A5 JP 2023516925 A5 JP2023516925 A5 JP 2023516925A5 JP 2022550778 A JP2022550778 A JP 2022550778A JP 2022550778 A JP2022550778 A JP 2022550778A JP 2023516925 A5 JP2023516925 A5 JP 2023516925A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence number
- optionally
- lcdr2
- hcdr1
- lcdr3
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2002581.3A GB202002581D0 (en) | 2020-02-24 | 2020-02-24 | Novel antibodies |
| GB2002581.3 | 2020-02-24 | ||
| PCT/GB2021/050459 WO2021171002A1 (en) | 2020-02-24 | 2021-02-24 | Novel antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023516925A JP2023516925A (ja) | 2023-04-21 |
| JP2023516925A5 true JP2023516925A5 (https=) | 2024-02-13 |
Family
ID=70108379
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022550778A Pending JP2023516925A (ja) | 2020-02-24 | 2021-02-24 | 新規の抗体 |
| JP2022550813A Pending JP2023514437A (ja) | 2020-02-24 | 2021-02-24 | Ｅｘ ｖｉｖｏガンマデルタｔ細胞集団 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022550813A Pending JP2023514437A (ja) | 2020-02-24 | 2021-02-24 | Ｅｘ ｖｉｖｏガンマデルタｔ細胞集団 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US20230090901A1 (https=) |
| EP (3) | EP4110387B1 (https=) |
| JP (2) | JP2023516925A (https=) |
| KR (2) | KR20220164473A (https=) |
| CN (2) | CN115697401A (https=) |
| AU (2) | AU2021228266A1 (https=) |
| BR (2) | BR112022016894A2 (https=) |
| CA (2) | CA3168973A1 (https=) |
| CL (1) | CL2022002296A1 (https=) |
| CO (2) | CO2022013542A2 (https=) |
| EC (1) | ECSP22074030A (https=) |
| GB (1) | GB202002581D0 (https=) |
| IL (2) | IL295696A (https=) |
| MX (2) | MX2022010239A (https=) |
| PE (1) | PE20230438A1 (https=) |
| WO (2) | WO2021171003A1 (https=) |
| ZA (1) | ZA202209699B (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202006989D0 (en) * | 2020-05-12 | 2020-06-24 | Gammadelta Therapeutics Ltd | Methods for isolating gamma delta t cells |
| MX2023009544A (es) | 2021-02-17 | 2023-11-28 | Gammadelta Therapeutics Ltd | Anticuerpos anti-variable delta 1 de tcr multiespecíficos. |
| CN119080924B (zh) * | 2024-07-04 | 2025-02-25 | 上海交通大学医学院附属第九人民医院 | 一种单克隆免疫球蛋白及其用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL297773B2 (en) * | 2014-11-17 | 2024-07-01 | Adicet Bio Inc | Engineered gamma delta t-cells |
| AU2016274633B2 (en) * | 2015-06-09 | 2022-04-21 | Gammadelta Therapeutics Ltd | Methods for the production of TCR gamma delta+ T cells |
| US11299708B2 (en) * | 2016-05-12 | 2022-04-12 | Adicet Bio, Inc. | Methods for selective expansion of γδ T-cell populations and compositions thereof |
| GB201818243D0 (en) | 2018-11-08 | 2018-12-26 | Gammadelta Therapeutics Ltd | Methods for isolating and expanding cells |
| JP2022545196A (ja) * | 2019-08-16 | 2022-10-26 | ガンマデルタ セラピューティクス リミテッド | 抗ｔｃｒデルタ可変１抗体の治療的使用 |
-
2020
- 2020-02-24 GB GBGB2002581.3A patent/GB202002581D0/en not_active Ceased
-
2021
- 2021-02-24 MX MX2022010239A patent/MX2022010239A/es unknown
- 2021-02-24 CA CA3168973A patent/CA3168973A1/en active Pending
- 2021-02-24 US US17/801,786 patent/US20230090901A1/en active Pending
- 2021-02-24 EP EP21709758.3A patent/EP4110387B1/en active Active
- 2021-02-24 CA CA3172340A patent/CA3172340A1/en active Pending
- 2021-02-24 BR BR112022016894A patent/BR112022016894A2/pt unknown
- 2021-02-24 CN CN202180028136.1A patent/CN115697401A/zh active Pending
- 2021-02-24 PE PE2022001812A patent/PE20230438A1/es unknown
- 2021-02-24 WO PCT/GB2021/050460 patent/WO2021171003A1/en not_active Ceased
- 2021-02-24 MX MX2022010383A patent/MX2022010383A/es unknown
- 2021-02-24 EP EP21709757.5A patent/EP4110813A1/en active Pending
- 2021-02-24 KR KR1020227029501A patent/KR20220164473A/ko active Pending
- 2021-02-24 AU AU2021228266A patent/AU2021228266A1/en active Pending
- 2021-02-24 US US17/904,890 patent/US20230159638A1/en active Pending
- 2021-02-24 AU AU2021225390A patent/AU2021225390A1/en active Pending
- 2021-02-24 KR KR1020227033455A patent/KR20220145894A/ko active Pending
- 2021-02-24 IL IL295696A patent/IL295696A/en unknown
- 2021-02-24 EP EP25177102.8A patent/EP4591882A3/en active Pending
- 2021-02-24 CN CN202180030584.5A patent/CN115461369A/zh active Pending
- 2021-02-24 JP JP2022550778A patent/JP2023516925A/ja active Pending
- 2021-02-24 WO PCT/GB2021/050459 patent/WO2021171002A1/en not_active Ceased
- 2021-02-24 IL IL295852A patent/IL295852A/en unknown
- 2021-02-24 BR BR112022016671A patent/BR112022016671A2/pt unknown
- 2021-02-24 JP JP2022550813A patent/JP2023514437A/ja active Pending
-
2022
- 2022-08-23 CL CL2022002296A patent/CL2022002296A1/es unknown
- 2022-08-30 ZA ZA2022/09699A patent/ZA202209699B/en unknown
- 2022-09-21 CO CONC2022/0013542A patent/CO2022013542A2/es unknown
- 2022-09-22 EC ECSENADI202274030A patent/ECSP22074030A/es unknown
- 2022-09-22 CO CONC2022/0013633A patent/CO2022013633A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12215163B2 (en) | CD25 antibodies | |
| RU2020124623A (ru) | Антитела, специфичные к гетеродимеру cd3-дельта/эпсилон | |
| JP2018512170A5 (https=) | ||
| JP2024522360A5 (https=) | ||
| JP2021500916A5 (https=) | ||
| JP2020536488A5 (https=) | ||
| US20050176028A1 (en) | Deimmunized binding molecules to CD3 | |
| JP2014526898A5 (https=) | ||
| JP2023516925A5 (https=) | ||
| JP2018537962A5 (https=) | ||
| JP2021514973A5 (https=) | ||
| KR20110040886A (ko) | 프로스타글란딘 ｅ2 결합 단백질 및 이의 용도 | |
| JP2015523962A5 (https=) | ||
| RU2014148502A (ru) | Человеческие антитела к fel d1 и способы их применения | |
| CN104822704A (zh) | 针对分化簇3(cd3)的人源化的抗体 | |
| RU2017134495A (ru) | Антитела к альфа-рецептору собачьего интерлейкина-4 | |
| CN101512008A (zh) | 白介素-13结合蛋白 | |
| JP2015535828A5 (https=) | ||
| RU2012127381A (ru) | Гуманизированные антитела против il-10 для лечения системной красной волчанки (sle) | |
| JP2022533538A5 (https=) | ||
| RU2012103212A (ru) | Tlr3 связывающие агенты | |
| JP2009509538A5 (https=) | ||
| JP2021512652A5 (https=) | ||
| JP2023545183A5 (https=) | ||
| JP2023510844A5 (https=) |